C12N 2015/8527
For producing animal models
Official title: {for producing animal models, e.g. for tests or diseases}
C12N2015/8527 (For producing animal models) appears on 188 US grants and 346 published applications in this corpus.
Search patents in C12N- Granted patents
- 188
- Published applications
- 346
- Assignees
- 183
- Inventors
- 654
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 5 |
| 2011 | 0 | 1 |
| 2012 | 1 | 4 |
| 2013 | 1 | 5 |
| 2014 | 3 | 11 |
| 2015 | 9 | 17 |
| 2016 | 7 | 23 |
| 2017 | 14 | 24 |
| 2018 | 12 | 44 |
| 2019 | 15 | 52 |
| 2020 | 15 | 25 |
| 2021 | 26 | 30 |
| 2022 | 23 | 28 |
| 2023 | 16 | 24 |
| 2024 | 21 | 25 |
| 2025 | 13 | 12 |
| 2026 | 12 | 12 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Method for constructing murine model with mutations in csflr gene and application thereof14 Jul 2026US 12,677,811 B2Beijing Tiantan Hospital, Capital Medical University
- Methods of treatment with aminolevulinic acid synthase 2 (ALAS2) modulators30 Jun 2026US 12,667,087 B2Agios Pharmaceuticals, Inc.
- Exon-humanized mouse30 Jun 2026US 12,668,810 B2Transgenic Inc.
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Methods and compositions for insertion of antibody coding sequences into a safe harbor locus1 Oct 2026US 2026/0297613 A1Regeneron Pharmaceuticals, Inc.
- Chimeric antigen receptors targeted to psca20 Aug 2026US 2026/0242509 A1City of Hope
- Brain-derived neurotrophic factor-nano luciferase transgenic rodents and methods of use thereof13 Aug 2026US 2026/0231914 A1University of Florida Research Foundation, Inc.
- Transcription modulation in animals using crispr/cas systems16 Jul 2026US 2026/0201410 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015
- Isolation of novel AAV's and uses thereof63US 9,596,835 B2University of Massachusetts · 2017
- Optically controlled CNS dysfunction58US 8,932,562 B2The Board of Trustees of the Leland Stanford Junior University · 2015
- Methods and compositions for the targeted modification of a genome54US 9,228,208 B2Regeneron Pharmaceuticals, Inc. · 2016
- Optically controlled CNS dysfunction40US 9,421,258 B2The Board of Trustees of the Leland Stanford Junior University · 2016